For patients
You can either register yourself or be referred by your primary care physician, specialist.
Lipid metabolism disorders are among the most common cardiovascular risk factors. Although the use of statins can be carried out easily and without major side effects in many patients, there are always questions for special patients.
Other experts from the USZ, such as Prof. Arnold von Eckardstein, are also available to us. In addition to clarification and improved drug treatment, innovative therapies such as PCSK9 inhibitors or, in rare cases, invasive therapy such as LDL-apheresis can be considered.
You can either register yourself or be referred by your primary care physician, specialist.
University Hospital Zurich
University Heart Center Zurich
Rämistrasse 100
8091 Zurich